Literature DB >> 16572282

Anti-neutrophil cytoplasmic antibodies in leprosy.

Fernando Luiz Barros Edington1, Maria Olívia Amado Ramos Bacellar, Paulo Roberto Machado, Lúcio Barbosa, Eliana Reis, Mitermayer Reis, Mittermayer Barreto Santiago.   

Abstract

INTRODUCTION: Anti-Neutrophil Cytoplasmic Antibodies (ANCA) are auto-antibodies directed to intracellular components of neutrophils and used to be considered as present almost exclusively in granulomatous vasculitis. Recently, these auto-antibodies have been found in other autoimmune disorders as well as infectious diseases.
MATERIALS AND METHODS: We studied patients with leprosy confirmed by bacilloscopy and/or skin biopsy, in reaction phase from the Ambulatório de Hanseníase do Hospital Universitário Professor Edgar Santos. ANCA and Antinuclear antibodies (ANA) were determined by indirect immunofluorescence using commercially available kits.
RESULTS: Twenty patients were enrolled in our study, nine males and 11 females. The mean age was 36.9+/-18.2 years. ANCA were present only in one patient, with a perinuclear staining pattern (p-ANCA), and no patient tested positive for ANA. DISCUSSION: Although other studies have shown the presence of ANCA in leprosy, the low frequency of these antibodies in leprosy sera demonstrated in the present study illustrates the high specificity of ANCA for the diagnosis of Wegener granulomatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572282     DOI: 10.1007/s10067-006-0281-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  Rational use of ANCA in the diagnosis of vasculitis.

Authors:  A Wiik
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

2.  Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study.

Authors:  E Röther; T Schochat; H H Peter
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Endocarditis associated with ANCA.

Authors:  A Soto; C Jorgensen; F Oksman; L H Noel; J Sany
Journal:  Clin Exp Rheumatol       Date:  1994 Mar-Apr       Impact factor: 4.473

4.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

5.  Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy.

Authors:  B F Freire; A A Ferraz; E Nakayama; S Ura; T T Queluz
Journal:  Int J Lepr Other Mycobact Dis       Date:  1998-12

6.  Anti-neutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: relationship to HLA-DR phenotypes, rheumatoid factor, anti-nuclear antibodies and disease severity.

Authors:  E Röther; D Metzger; B Lang; I Melchers; H H Peter
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study.

Authors:  G Gregorini; A Ferioli; F Donato; P Tira; L Morassi; R Tardanico; L Lancini; R Maiorca
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

8.  Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India.

Authors:  Vandana Pradhan; S S Badakere; U Shankar Kumar
Journal:  Lepr Rev       Date:  2004-03       Impact factor: 0.537

9.  Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease.

Authors:  E Romas; B Paspaliaris; A J d'Apice; P R Elliott
Journal:  Aust N Z J Med       Date:  1992-12

Review 10.  [Leprosy in Brazil].

Authors:  Marcelo Grossi Araújo
Journal:  Rev Soc Bras Med Trop       Date:  2003-07-31       Impact factor: 1.581

View more
  6 in total

1.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

2.  Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis.

Authors:  I Lima; R C Oliveira; M S Cabral; A Atta; S Marchi; E Reis; M G Reis; L Barbosa; M B Santiago
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

3.  Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association.

Authors:  Luiz Sergio Guedes-Barbosa; Cristovão Mangueira; Morton Scheinberg
Journal:  Clin Rheumatol       Date:  2007-12-18       Impact factor: 2.980

4.  Uveitic Glaucoma and Hansen's disease, A case report.

Authors:  Ana Roldan-Vasquez; Estefania Roldan-Vasquez; Ana M Vasquez
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-22

Review 5.  Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Authors:  Konstantin N Konstantinov; Suzanne N Emil; Marc Barry; Susan Kellie; Antonios H Tzamaloukas
Journal:  ISRN Nephrol       Date:  2013-02-19

6.  Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region.

Authors:  Clea Nazaré Carneiro Bichara; Carlos David Araújo Bichara; Camila Tostes; Marinete Marins Povoa; Juarez Antonio Simões Quaresma; Marília Brasil Xavier
Journal:  Infect Dis Poverty       Date:  2017-06-01       Impact factor: 4.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.